Dr. Agarwal’s Health Care reported consolidated revenue of ₹4.99 billion and net profit of ₹296.9 million for Q2 FY2026, marking a 71% year-on-year jump in profit. The company also crossed ₹10 billion in half-yearly income, driven by network expansion and rising surgical volumes.
India’s largest eye care chain by revenue, Dr. Agarwal’s Health Care Ltd., delivered robust financial results for the September 2025 quarter. The company’s revenue from operations rose 19.7% year-on-year to ₹4.99 billion, while net profit surged 71% to ₹296.9 million. EBITDA for the quarter stood at ₹1.44 billion, up 21.2% YoY, reflecting strong operational efficiency.
The company expanded its footprint to 258 eye care centers, adding 24 new facilities in H1 FY2026. It also performed over 157,000 surgeries during the half-year, a 14.6% increase from the previous year. With total income crossing ₹10 billion in six months, Dr. Agarwal’s is on track to meet its full-year growth targets.
-
Revenue from operations: ₹4.99 billion (↑19.7% YoY)
-
Net profit: ₹296.9 million (↑71% YoY)
-
EBITDA: ₹1.44 billion (↑21.2% YoY)
-
Network: 258 centers; 24 added in H1
-
Surgeries performed: 157,281 (↑14.6% YoY)
-
Half-year income: ₹10 billion milestone crossed
Sources: ScanX, Moneycontrol, Economic Times